Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-21

Clinical Trial Update: Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cranberry supplementation to prevent urinary tract infections in patients with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cranberry (Cranberry extract)

Snippet

Sponsor: Rennes University Hospital | Conditions: Multiple Sclerosis, Urinary Tract Infections | Phase 3 | Status: COMPLETED